Maxcyte (MXCT) Amortizatization of Intangibles (2020 - 2026)
Maxcyte (MXCT) posted quarterly Amortizatization of Intangibles of $437000.0 for Q1 2026, down 50.57% year-over-year from $884000.0 in Q1 2025, and up 2.34% quarter-over-quarter from $427000.0 in Q4 2025.
Maxcyte (MXCT) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Amortizatization of Intangibles for 7 consecutive years, with $437000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 50.57% year-over-year to $437000.0; the TTM figure through Mar 2026 stood at $2.2 million (down 57.24% YoY), while the FY2025 annual figure was $2.6 million, down 57.61% from the prior year.
- Amortizatization of Intangibles advanced to $437000.0 in Q1 2026 per MXCT's latest filing, from $427000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.0 million in Q4 2023 and bottomed at $33200.0 in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $1.1 million across 5 years, with a median of $1.2 million in 2024.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles surged 5110.84% — and 2025, when it slumped 64.12%.
- Maxcyte's Amortizatization of Intangibles stood at $1.5 million in 2022, then surged by 32.37% to $2.0 million in 2023, then slumped by 40.41% to $1.2 million in 2024, then sank by 64.12% to $427000.0 in 2025, then grew by 2.34% to $437000.0 in 2026.
- Business Quant data shows MXCT's Amortizatization of Intangibles at $437000.0 in Q1 2026, $427000.0 in Q4 2025, and $584000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn | 401,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 401,000.00 |
| Jun 30, 2026 | 401,000.00 |
| Mar 31, 2026 | 437,000.00 |
| Mar 31, 2026 | 437,000.00 |
| Dec 31, 2025 | 427,000.00 |
| Dec 31, 2025 | 427,000.00 |
| Sep 30, 2025 | 584,000.00 |
| Sep 30, 2025 | 584,000.00 |
| Jun 30, 2025 | 751,000.00 |
| Jun 30, 2025 | 751,000.00 |
| Mar 31, 2025 | 884,000.00 |
| Mar 31, 2025 | 884,000.00 |
| Dec 31, 2024 | 1.19 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.39 Mn |
| Sep 30, 2024 | 1.39 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Mar 31, 2024 | 1.98 Mn |
| Mar 31, 2024 | 1.98 Mn |